Your browser doesn't support javascript.
loading
Considerations from an International Regulatory and Pharmaceutical Industry (IQ MPS Affiliate) Workshop on the Standardization of Complex In Vitro Models in Drug Development.
Tomlinson, Lindsay; Ramsden, Diane; Leite, Sofia Batista; Beken, Sonja; Bonzo, Jessica A; Brown, Paul; Candarlioglu, Pelin L; Chan, Tom S; Chen, Eugene; Choi, Colin K; David, Rhiannon; Delrue, Nathalie; Devine, Patrick J; Ford, Kevin; Garcia, Martha Iveth; Gosset, James R; Hewitt, Philip; Homan, Kimberly; Irrechukwu, Onyi; Kopec, Anna K; Liras, Jennifer L; Mandlekar, Sandhya; Raczynski, Arek; Sadrieh, Nakissa; Sakatis, Melanie Z; Siegel, Jeffrey; Sung, Kyung; Sunyovszki, Ilona; Van Vleet, Terry R; Ekert, Jason E; Hardwick, Rhiannon N.
Afiliación
  • Tomlinson L; Global Pathology, Pfizer Inc., Cambridge, MA, 02140, USA.
  • Ramsden D; DMPK Oncology, AstraZeneca, Boston, MA, 02451, USA.
  • Leite SB; European Commission Joint Research Centre, Ispra, 21027, Italy.
  • Beken S; Federal Agency for Medicines and Health Products, Brussels, 1210, Belgium.
  • Bonzo JA; Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA.
  • Brown P; Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA.
  • Candarlioglu PL; Complex In Vitro Models, GSK, Stevenage, SG1 2NY, UK.
  • Chan TS; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, 06877, USA.
  • Chen E; DMPK, Genentech, South San Francisco, CA, 94080, USA.
  • Choi CK; Preclinical Safety, Biogen, Cambridge, MA, 02142, USA.
  • David R; Clinical Pharmacology & Safety Sciences, AstraZeneca, Cambridge, CB2 0AA, UK.
  • Delrue N; Organisation for Economic Co-operation and Development, Paris, 75016, France.
  • Devine PJ; Discovery Toxicology, Bristol Myers Squibb, San Diego, CA, 09130, USA.
  • Ford K; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Science, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA.
  • Garcia MI; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Science, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA.
  • Gosset JR; DMPK, Pfizer Inc., Cambridge, MA, 02139, USA.
  • Hewitt P; Chemical and Preclinical Safety, Merck Healthcare KGaA, 64293, Darmstadt, Germany.
  • Homan K; Complex in Vitro Systems Group, Genentech, South San Francisco, CA, 94080, USA.
  • Irrechukwu O; Preclinical Sciences and Translational Safety, Johnson and Johnson Innovation Medicine, Spring House, PA, 19002, USA.
  • Kopec AK; Drug Safety Research & Development, Pfizer Inc., Groton, CT, 06340, USA.
  • Liras JL; Pharmacokinetics, Dynamics & Metabolism-Medicine Design, Pfizer, Cambridge, MA, 02139, USA.
  • Mandlekar S; Clinical Pharmacology, Genentech, South San Francisco, CA, 94080, USA.
  • Raczynski A; Preclinical Safety Assessment, Vertex Pharmaceuticals Inc., Boston, MA, 02210, USA.
  • Sadrieh N; Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA.
  • Sakatis MZ; Non-Clinical Safety, In Vitro/In Vivo Translation, GSK R&D, Ware, SG12 9TJ, UK.
  • Siegel J; Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA.
  • Sung K; Center for Biologics Evaluation and Research, Office of Cellular Therapy and Human Tissue, Cellular and Tissue Therapy Branch, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA.
  • Sunyovszki I; Translational Cellular Sciences, Biogen, Cambridge, MA, 02142, USA.
  • Van Vleet TR; AbbVie, Inc., North Chicago, IL, 60064, USA.
  • Ekert JE; UCB Pharma, Cambridge, MA, 02140, USA.
  • Hardwick RN; Discovery Toxicology, Bristol Myers Squibb, San Diego, CA, 09130, USA.
Adv Biol (Weinh) ; : e2300131, 2023 Oct 09.
Article en En | MEDLINE | ID: mdl-37814378

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article